Abstract
Nonsense-mediated mRNA decay (NMD) functions to ensure quality gene expression by degrading mRNAs that prematurely terminate translation. By so doing, it eliminates the production of potentially deleterious truncated proteins. NMD also degrades certain naturally occurring transcripts as a means of achieving proper levels of gene expression. With the exception of prokaryotes, NMD typifies all organisms that have been examined. As an example of its importance, NMD is required for the viability of mammalian blastocysts in culture as well as mammalian embryos in utero. The repertoire of factors that mediate NMD is larger in C. elegans, D. melanogaster, mammalian cells and, possibly, A. thaliana, than it is in S. cerevisiae and S. pombe. NMD requires not only a premature termination codon but also a downstream element. Whereas this element in S. cerevisiae, S. pombe, C. elegans, D. melanogaster and plants is debatably either a short cis-acting mRNA sequence or an abnormal 3 untranslated region, it is a splicing-generated exon junction complex of proteins in mammalian cells. In fact, NMD may have provided a selective pressure for where introns colonize within mammalian genes. There also appear to be differences among different eukaryotes as to whether NMD is restricted to newly synthesized mRNA or can also target steady-state mRNA. In summary, despite the conservation of NMD in eukaryotes, different mechanisms have evolved to define those premature termination codons that elicit NMD.
Keywords: nonsense-mediated mrna decay, rna surveillance, premature termination of translation, upf proteins
Current Genomics
Title: Nonsense-Mediated mRNA Decay: A Comparative Analysis of Different Species
Volume: 5 Issue: 3
Author(s): L. E. Maquat
Affiliation:
Keywords: nonsense-mediated mrna decay, rna surveillance, premature termination of translation, upf proteins
Abstract: Nonsense-mediated mRNA decay (NMD) functions to ensure quality gene expression by degrading mRNAs that prematurely terminate translation. By so doing, it eliminates the production of potentially deleterious truncated proteins. NMD also degrades certain naturally occurring transcripts as a means of achieving proper levels of gene expression. With the exception of prokaryotes, NMD typifies all organisms that have been examined. As an example of its importance, NMD is required for the viability of mammalian blastocysts in culture as well as mammalian embryos in utero. The repertoire of factors that mediate NMD is larger in C. elegans, D. melanogaster, mammalian cells and, possibly, A. thaliana, than it is in S. cerevisiae and S. pombe. NMD requires not only a premature termination codon but also a downstream element. Whereas this element in S. cerevisiae, S. pombe, C. elegans, D. melanogaster and plants is debatably either a short cis-acting mRNA sequence or an abnormal 3 untranslated region, it is a splicing-generated exon junction complex of proteins in mammalian cells. In fact, NMD may have provided a selective pressure for where introns colonize within mammalian genes. There also appear to be differences among different eukaryotes as to whether NMD is restricted to newly synthesized mRNA or can also target steady-state mRNA. In summary, despite the conservation of NMD in eukaryotes, different mechanisms have evolved to define those premature termination codons that elicit NMD.
Export Options
About this article
Cite this article as:
Maquat E. L., Nonsense-Mediated mRNA Decay: A Comparative Analysis of Different Species, Current Genomics 2004; 5 (3) . https://dx.doi.org/10.2174/1389202043349453
DOI https://dx.doi.org/10.2174/1389202043349453 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Structural Basis of Tetherin Function
Current HIV Research p53-Independent Activities of MDM2 and Their Relevance to Cancer Therapy
Current Cancer Drug Targets Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells
Anti-Cancer Agents in Medicinal Chemistry Coordinated Expression of Pax-5 and FAK1 in Metastasis
Anti-Cancer Agents in Medicinal Chemistry Adrenomedullin-RAMP2 System in Cardiovascular Development and Homeostasis
Current Hypertension Reviews Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Stem Cell Regenerative Potential Combined with Nanotechnology and Tissue Engineering for Myocardial Regeneration
Current Stem Cell Research & Therapy Microenvironmental Regulation of Cancer Stem Cell Phenotypes
Current Stem Cell Research & Therapy Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer
Current Drug Targets Targeting the Atypical Chemokine Receptor ACKR3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization
Current Topics in Medicinal Chemistry Chemotherapeutic Agents That Induce Mitochondrial Apoptosis
Current Cancer Drug Targets Antiviral Drugs that Target Cellular Proteins May Play Major Roles in Combating HIV Resistance
Current Pharmaceutical Design Targeting IGF-I, IGFBPs and IGF-I Receptor System in Cancer: The Current and Future in Breast Cancer Therapy
Recent Patents on Anti-Cancer Drug Discovery Radioiodinated Agents for Imaging Multidrug Resistant Tumors
Medicinal Chemistry Strategies for the Biological Evaluation of Gold Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Electrically-Assisted Nucleic Acids Delivery to Tissues In Vivo: Where Do We Stand?
Current Pharmaceutical Design PET Imaging with [<sup>68</sup>Ga]NOTA-RGD for Prostate Cancer: A Comparative Study with [<sup>18</sup>F]Fluorodeoxyglucose and [<sup>18</sup>F]Fluoroethylcholine
Current Cancer Drug Targets Oxidative Stress, Mitochondrial Dysfunction, and Stress Signaling in Alzheimers Disease
Current Alzheimer Research Current Strategy for Cisplatin Delivery
Current Cancer Drug Targets Current and Future Therapeutic Targets: A Review on Treating Head and Neck Squamous Cell Carcinoma
Current Cancer Drug Targets